A prospective multi-centre Phase III validation study of AZGP1 as a biomarker in localized prostate cancer

Zhang, A. (Speaker)

Activity: Talk or presentationPresentation

Period13 Feb 201715 Feb 2017
Event titleLorne Cancer Conference
Event typeConference
LocationAustralia, Victoria
Degree of RecognitionLocal